Replies to post #23725 on Xeriant Inc (XERI)

[quester614]

MORE LAME BS. I'm not blaming anything. IT's in the filings. There were 8-K's released that showed time extension on XTI, MC, and Auctus. Now almost 2 months without any word of another extension. It does take some time for the lawyers to get their cases together. Auctus will be the first to collect since they deal with these types of SCAM companies all the time as a KNOWN TOXIC LENDER. The only group that doesn't profit are the investors that believe in this SCAM POS. Auctus will dump 100's millions of shares to recoup their money without one thought of the retail investor.

TIME IS SHORT
TIC TOC

[Smartypants2]

The assumption that XERI would pay so much money and give away so much of the potential revenue from the sale of Retacell-enhanced products WITHOUT REQUIRING ANY ADDITIONAL INPUT OR CONTRIBUTIONS IN PRODUCT DEVELOPMENT from Movychem, beyond the transfer of the basic Retacell IP, is totally absurd and ill-informed!

In fact, had Movychem wished to wash its hands of any additional responsibilities towards the practical application and commercialization of Retacell, such a disclaimer would have been clearly included in their JV Agreement. In addition, it never would have attempted (and subsequently failed) to provide those services, as so indicated in the S1/A.

Movychem may have spent 20 years developing Retacell, but when it came to helping XERIANT produce a commercially viable product around it, they stopped too far from the finish line. XERI would have been crazy to pay them that $2 million under the circumstances!